USPTO serial 88383848
SWITCHBACK BIO
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SMITH, BRIDGETT G
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SWITCHBACK BIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations for the prevention of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations for the treatment and prevention of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceuticals, namely, anti-infectives; Antibacterial pharmaceuticals; Biometallic compounds being a component in pharmaceutical preparations for Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a pill or capsule that facilitate the delivery of pharmaceutical preparations; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Therapeutic pharmaceutical for the treatment of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 7, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 22, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 21, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 17, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Mar 17, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 23, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 21, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 21, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 21, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 10, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 10, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 10, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 7, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 6, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 4, 2021 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| May 3, 2021 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| May 3, 2021 | PETG | PETITION TO REVIVE-GRANTED | — |
| May 3, 2021 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| May 3, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 3, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 1, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 11, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 10, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 3, 2020 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Nov 3, 2020 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Nov 3, 2020 | PETG | PETITION TO REVIVE-GRANTED | — |
| Nov 3, 2020 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Nov 2, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 2, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 1, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 11, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 10, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 10, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 15, 2020 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jun 13, 2020 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jun 13, 2020 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jun 13, 2020 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jun 8, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 8, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 1, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 1, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 6, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 6, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 17, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 29, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 25, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 25, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jun 25, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 25, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 25, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 22, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 30, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2019 | NWAP | NEW APPLICATION ENTERED | — |